#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Osteogenesis imperfecta Hydrocephalus Breast angiosarcoma metastatic Spinal cord injury Extraskeletal ossification Acute hepatic failure Hyperchylomicronaemia Hairy cell leukaemia recurrent Hereditary ataxia Congenital growth hormone deficiency Prader-Willi syndrome Duchenne muscular dystrophy Stevens-Johnson syndrome Liposarcoma metastatic More trials…

    Learn about Rare Diseases

    MELAS syndrome Cholangitis sclerosing – Diagnostics Medulloblastoma recurrent – Life with Disease Netherton’s syndrome – Life with Disease Hepatic angiosarcoma – Basic Information Aicardi-Goutieres syndrome – Basic Information IgA nephropathy – Basic Information Idiopathic pulmonary fibrosis – Basic Information Erdheim-Chester disease – Basic Information Marginal zone lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mexiletine Bictegravir Regn5668 Teprotumumab Ethanol (96 Per Cent) Rebisufligene Etisparvovec Tipranavir Donepezil Hydrochloride Fluorodopa (18F) Dexamfetamine Sulfate Zagociguat Iohexol Iph5201 Resamirigene Bilparvovec Brimonidine Sirolimus Benralizumab Amsacrine Ribonucleic Acid K30 Losartan More therapies…

    Learn about Your Condition

    Contusion Round cell liposarcoma Primary amyloidosis Small intestine carcinoma Tricuspid valve disease CDKL5 deficiency disorder Uterine leiomyosarcoma Mast cell activation syndrome Femoral hernia Supraventricular tachycardia Crigler-Najjar syndrome Haemoglobinuria Pneumococcal infection Gaucher's disease type I Mantle cell lymphoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety of Edoxaban for Patients with Porto-Sinusoidal Vascular Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Porto-sinusoidal vascular disorder
    Investigated Drugs:
    • Edoxaban
    Austria

  • Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

    Recruiting

    2 1
    Investigated Drugs:
    • Dnth103
    Denmark France Italy The Netherlands Poland Spain

  • Study of Azacitidine, Venetoclax, and Tagraxofusp for Patients with Higher-Risk Chronic Myelomonocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    Investigated Drugs:
    • TAGRAXOFUSP
    • Venetoclax
    Germany Italy Spain

  • Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mexiletine
    • Mexiletine Hydrochloride
    Belgium France Germany Italy

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Insomnia
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • Study on the Effects and Safety of Daratumumab, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Plasmablastic Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasmablastic lymphoma
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Betamethasone Sodium Phosphate
    Italy
Previous Page
1 … 257 258 259 260 261 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!